Nicholas Investments Partners »

Halozyme Therapeutics shares owned by Nicholas Investments Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Nicholas Investments Partners from 13F filings

Historical chart of Nicholas Investments Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Nicholas Investments Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Nicholas Investments Partners

Quarter filed Position value Share count Share price at filing
2010-12-31 $517k 65k 7.92